US Patent Issued to Beijing Innocare Pharma Tech on Aug. 19 for "Indoline-1-formamide compound, preparation method therefor, and medical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,666, issued on Aug. 19, was assigned to Beijing Innocare Pharma Tech Co. Ltd. (Beijing).

"Indoline-1-formamide compound, preparation method therefor, and medical use thereof" was invented by Xiangyang Chen (Beijing), Yucheng Pang (Beijing) and Yingxiang Gao (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a new indoline-1-carboxamide compound for regulating or inhibiting the activity of vascular endothelial growth factor receptor (VEGFR), a preparation method therefor, and the medical use thereof. Specifically, the present invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt thereof...